Latest filing published 13 Jul 2026 for UNITED THERAPEUTICS Corp. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ray Kurzweil appears in our data through filings on UNITED THERAPEUTICS Corp shares, published by SEC (Form 4). Over a trading history stretching from 26 June 2021 to 9 July 2026, the count stands at 11 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 13 July 2026 came the latest disclosure, an option exercise in UNITED THERAPEUTICS Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations